Li Tang

photo placeholder image

Tenure Track Assistant Professor

li.tang@epfl.ch 41 21 693 09 37 http://tang-lab.epfl.ch/

EPFL STI IBI-STI LBI
MED 1 2826 (Bâtiment MED)
Station 9
CH-1015 Lausanne

41 21 693 09 37
41 21 693 07 56
Office: MED 1 2826
EPFL > STI > IBI-STI > LBI

Web site: Web site: https://tang-lab.epfl.ch/

41 21 693 09 37
EPFL > SV > SV-SSV > SSV-ENS

Web site: Web site: https://sv.epfl.ch/education

EPFL STI IMX-GE
MED 1 2826 (Bâtiment MED)
Station 9
CH-1015 Lausanne

41 21 693 09 37
Office: MED 1 2826
EPFL > STI > IMX > IMX-GE

41 21 693 09 37
EPFL > STI > STI-SMX > SMX-ENS

vCard
Administrative data

Fields of expertise

Immunoengineering
Biomaterials
Drug delivery
Immunotherapy
Nanomedicine
Vaccine development

Teaching & PhD

Teaching

Materials Science and Engineering

Life Sciences Engineering

PhD Programs

Doctoral Program in Materials Science and Engineering

Doctoral Program in Biotechnology and Bioengineering

Doctoral Program in Molecular Life Sciences

Doctoral Program in Chemistry and Chemical Engineering

PhD Students

Bonati Lucia, Gao Min, Hu Xiaomeng, Kurum Armand, Lei Kewen, Li Rongrong, Prange Céline Jasmin, Xie Yuqing, Zhao Yang,

Courses

Scientific literature analysis in bioengineering

Students are given the means to dig effectively into modern scientific literature in the multidisciplinary field of bioengineering. The method relies on granting sufficient time to become familiar with the background and hypotheses, on effective support during the analysis and on oral assessment.

Practical - Tang Lab

In this course, the students will learn the basics skills in cancer immunotherapy and immunoengineering. Open to 4 students.

Immunoengineering

Immunoengineering is an emerging field where engineering principles are grounded in immunology. This course provides students a broad overview of how engineering approaches can be utilized to study immunology, model immune systems, modulate immune response, and develop novel immunotherapies.

Tissue engineering

(Coursebook not yet approved by the section)